We are monitoring the impact of COVID-19 on APAC Genome Editing Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 2670
Share on
Share on

Asia Pacific Genome Editing Market Research Report - Segmented By Application, Technology, End User & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) - Industry Analysis on Size, Share, Trends, COVID-19 Impact and Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 2670
Pages: 145

APAC Genome Editing Market Size (2021 to 2026)

The genome editing market size in the Asia Pacific is estimated to be USD 1.70 billion by 2026 and USD 0.82 billion in 2021, growing at a CAGR of 15.66% during the forecast period.

Genome editing is a branch of genetic engineering in which DNA is inserted, deleted, or replaced in the genome of a living organism with the aid of engineered nucleases, which are otherwise known as molecular scissors. They work by creating site-specific double-strand breaks at the desired locations in the genome.

MARKET DRIVERS:

During the forecast period, the APAC genome editing market is expected to see significant growth. Gene editing methods treat diseases that have a genetic basis, such as diabetes and cystic fibrosis. As funding for gene editing research grows, Japan is expected to emerge as a major player in the Asia Pacific region. Various institutions supporting genome editings in Japan, such as research institutes and universities, can be credited to the market's rapid growth. Over the last few years, the industry has been largely driven by the increased deployment of CRISPR genome editing technology and growing synthetic gene demand in various biotechnology fields. The development of CRISPR-based new diagnostic tools to reduce the harmful impact of the COVID-19 pandemic. Nanyang Technological University, for instance, created a CRISPR-based diagnostic tool called VaNGuard. This test may identify altered SARS-CoV-2 strains, boosting CRISPR genome editing technology's acceptance in the diagnostics field.

Due to increased R&D spending, increased government support for genomic research, technical improvements, and increased output of genetically modified crops, the genome editing market is now seeing significant growth. In recent years, companies have made considerable expenditures in R&D to create advanced technologies like CRISPR and TALEN. In the near future, the number of diseases and applications is anticipated to increase, expanding the scope of genome editing. Understanding the function of certain genes and processes in organ-specific stem cells, such as brain stem cells and spermatogonia stem cells, is one example.

MARKET RESTRAINTS:

The high cost of genomic equipment will restrict the market's expansion. A scarcity of skilled professionals also hinders the business due to medical workers being assigned to covid-19 frontlines. Low public awareness in this region and stringent government rules hinder the APAC genome editing market expansion.

Off-target mutation development, environmental imbalance, and illegal genome editing are among the key ethical issues. The general public has a negative view of gene editing. Several scientists have argued that genome editing should be restricted or banned. This has put a lot of pressure on companies that work with genome editing since they can't locate qualified individuals for clinical studies, slowing down innovation. As a result, it presents a significant impediment to the expansion of the genomic testing business in the Asia Pacific region. In a therapeutic setting, CRISPR genome editing may result in unexpected heritable genetic changes, which might pose long-term risks. All these are the challenges faced by the market.

This research report on the APAC genome editing market has been segmented and sub-segmented into the following categories:

By Application: 

  • Cell Line
  • Animal Genetic
  • Plant Genetic Engineering

By Technology: 

  • CRISPR
  • TALEN
  • ZFN
  • Antisense
  • Other Technologies

By End-User: 

  • Biotechnological & Pharmaceutical Companies
  • Academic and Government Research Institutes
  • Contract Research Organizations

By Country:

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

In low- and middle-income countries (LMICs) in the Asia-Pacific region, significant developments in genetic and genomic technology have revolutionized healthcare services. Although genetic services began as population-based disease prevention techniques, they have developed into clinic-based and therapeutic-oriented programs. Many healthcare systems in the region were unprepared for the demands of a clinical genetic program, and they have struggled to deal with both communicable and non-communicable diseases. Due to increased investments by the governments of the different nations in the area, China is anticipated to dominate the Asia Pacific area. The genome editing market is projected to be driven by growing development and research for genome editing and clinical trials throughout the forecast period. Furthermore, India’s measures to promote biotechnology companies are anticipated to boost the country's biotechnology business. As a result of these factors, the country's market growth is expected to contribute the highest share in the Asia Pacific region during the forecast period.

The Chinese genome editing market is projected to have fast growth in this region over the review period, followed by Japan, India, and other countries. The growth of China is attributed to factors such as advanced technologies in developing new novel drugs for genome editing, growing elder people population, and changing lifestyle, which may lead to chronic disorders of this APAC region likely to accelerate market growth. In April 2016, Japan invested nearly USD 76million for the next five years to create Japanese-owned genome editing technologies over the analysis period.

KEY MARKET PLAYERS:

A Few of the notable companies leading the Asia Pacific genome editing market profiled in the report are Thermo Fisher Scientific, Merck KGAA, Horizon Discovery Group Plc, Genscript Biotech Corporation, Sangamo Biosciences, Integrated DNA Technologies, Lonza Group Ltd, New England Biolabs, Origene Technologies, and Transposagen Biopharmaceuticals.

  1. Introduction

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

  1. Research Methodology

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

  1. Overview

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemiology                             

  1. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

  1. Market Segmentation

                5.1 Application                 

                                5.1.1 Introduction           

                                5.1.2 Cell Line Engineering           

                                5.1.3 Animal Genetic Engineering            

                                5.1.4 Plant Genetic Engineering

                                5.1.5 Y-o-Y Growth Analysis, By Application         

                                5.1.6 Market Attractiveness Analysis, By Application       

                                5.1.7 Market Share Analysis, By Application        

                5.2 Technology                 

                                5.3.1 Introduction           

                                5.3.2 CRISPR      

                                5.3.3 TALEN       

                                5.3.4 ZFN            

                                5.3.5 Antisense

                                5.3.6 Other Technologies             

                                5.3.7 Y-o-Y Growth Analysis, By Technology        

                                5.3.8 Market Attractiveness Analysis, By Technology      

                                5.3.9 Market Share Analysis, By Technology        

                5.3 End User                      

                                5.2.1 Introduction           

                                5.2.2 Biotechnological & Pharmaceutical Companies       

                                5.2.3 Academic and Government Research Institutes     

                                5.2.4 Contract Research Organizations   

                                5.2.5 Y-o-Y Growth Analysis, By End User             

                                5.2.6 Market Attractiveness Analysis, By End User           

                                5.2.7 Market Share Analysis, By End User             

  1. Geographical Analysis

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Application

                                                6.1.3.3 By Technology

                                                6.1.3.4 By End User

                                6.1.4 Market Attractiveness Analysis      

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Application

                                                6.1.4.3 By Technology

                                                6.1.4.4 By End User

                                6.1.5 Market Share Analysis       

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Application

                                                6.1.5.3 By Technology

                                                6.1.5.4 By End User

                6.2 China                             

                6.3 India                              

                6.4 Japan                            

                6.5 South Korea                               

                6.6 Australia                      

  1. Strategic Analysis

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five Analysis                             

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

  1. Market Leaders' Analysis

                8.1 Thermo Fisher Scientific                        

                                8.1.1 Overview 

                                8.1.2 Application Analysis            

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Merck KGAA                              

                8.3 Horizon Discovery Group Plc                               

                8.4 Genscript Biotech Corporation                           

                8.5 Sangamo Biosciences                             

                8.6 Integrated DNA Technologies                            

                8.7 Lonza Group Ltd                       

                8.8 New England Biolabs                              

                8.9 Origene Technologies                            

                8.10 Transposagen Biopharmaceuticals                 

  1. Competitive Landscape

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

  1. Market Outlook and Investment Opportunities

Appendix                                           

  1. a) List of Tables
  2. b) List of Figures
  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia Pacific Genome Editing Market, By Application, From 2021 to 2026 (USD Billion)
  2. Asia Pacific Cell Line Engineering Market, By Region, From 2021 to 2026 (USD Billion)
  3. Asia Pacific Animal Genetic Engineering Market, By Region, From 2021 to 2026 (USD Billion)
  4. Asia Pacific Plant Genetic Engineering Market, By Region, From 2021 to 2026 (USD Billion)
  5. Asia Pacific Genome Editing Market, By Technology, From 2021 to 2026 (USD Billion)
  6. Asia Pacific CRISPR Market, By Region, From 2021 to 2026 (USD Billion)
  7. Asia Pacific TALEN Market, By Region, From 2021 to 2026 (USD Billion)
  8. Asia Pacific ZFN Market, By Region, From 2021 to 2026 (USD Billion)
  9. Asia Pacific Antisense Market, By Region, From 2021 to 2026 (USD Billion)
  10. Asia Pacific Other Technologies Market, By Region, From 2021 to 2026 (USD Billion)
  11. Asia Pacific Genome Editing Market, By End User, From 2021 to 2026 (USD Billion)
  12. Asia Pacific Biotechnological & Pharmaceutical Companies Market, By Region, From 2021 to 2026 (USD Billion)
  13. Asia Pacific Academic and Government Research Institutes Market, By Region, From 2021 to 2026 (USD Billion)
  14. Asia Pacific Contract Research Organizations Market, By Region, From 2021 to 2026 (USD Billion)
  15. Japan Genome Editing Market, By Application, From 2021 to 2026 (USD Billion)
  16. Japan Genome Editing Market, By Technology, From 2021 to 2026 (USD Billion)
  17. Japan Genome Editing Market, By End User, From 2021 to 2026 (USD Billion)
  18. China Genome Editing Market, By Application, From 2021 to 2026 (USD Billion)
  19. China Genome Editing Market, By Technology, From 2021 to 2026 (USD Billion)
  20. China Genome Editing Market, By End User, From 2021 to 2026 (USD Billion)
  21. India Genome Editing Market, By Application, From 2021 to 2026 (USD Billion)
  22. India Genome Editing Market, By Technology, From 2021 to 2026 (USD Billion)
  23. India Genome Editing Market, By End User, From 2021 to 2026 (USD Billion)
  24. Australia Genome Editing Market, By Application, From 2021 to 2026 (USD Billion)
  25. Australia Genome Editing Market, By Technology, From 2021 to 2026 (USD Billion)
  26. Australia Genome Editing Market, By End User, From 2021 to 2026 (USD Billion)
  27. South Korea Genome Editing Market, By Application, From 2021 to 2026 (USD Billion)
  28. South Korea Genome Editing Market, By Technology, From 2021 to 2026 (USD Billion)
  29. South Korea Genome Editing Market, By End User, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample